Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

Autor: Pasquali, S, Maqueo, JD, Vela, J, Kyle, RA, Leong, T, Fritz, E, Suciu, S, Palva, IP, Oivanen, T, Corrado, C, Lastiri, FJ, Peest, D, Kildahl-Andersen, O, Maniatis, A, Alison, R, Clarke, M, Evans, V, Gray, R, Greaves, E, Hall, E, Hicks, C, James, S, Peto, R, Richards, S, Sinclair, D, Tooth, A, Wheatley, K, Avvisati, G, Boccadoro, M, Bugliosi, R, Mandelli, F, Petrucci, MT, Pileri, A, Tribalto, M, Alexanian, R, Delasalle, KB, Child, J, Dunn, J, MacLennan, I, Milligan, D, Mellstedt, H, Osterborg, A, Hjorth, M, Holmberg, E, Rodjer, S, Westin, J, Kamiya, O, Shimizu, K, Bergsagel, DE, Shustik, C, Hippe, E, Kjaersgaard, E, Turesson, I, Riccardi, A, Ucci, G, Blade, J, Fontanillas, M, De Rosa, L, Montuoro, A, Bartolucci, AA, Omura, GA, Stagg, M, Salmon, S, Tangen, C, Jacobs, P, Wood, L, Levy, LM, Grp, MTC

Publikováno v: JOURNAL OF CLINICAL ONCOLOGY. 16(12)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::d0d1192bdbdf3893ff446c65c42ecac6
http://ora.ox.ac.uk/objects/uuid:da6e5c6a-cb53-449c-9269-a7ec5a66df8b